Stenotrophomonas maltophilia Bacteremia Associated With Severe COVID-19: Successful Treatment With Appropriate Antimicrobial Therapy

Stenotrophomonas maltophilia, an opportunistic pathogen, can cause bacteremia in immunocompromised and debilitated patients. A 50-year-old man with severe coronavirus disease 2019 (COVID-19) was admitted to our hospital’s intensive care unit where he underwent extracorporeal membrane oxygenation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwahara, Masaatsu, Noma, Mitsuki, Sunakawa, Takuya, Shirai, Kunihiro, Kohama, Keisuke, Miyawaki, Atsushi, Hirata, Jun-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890587/
https://www.ncbi.nlm.nih.gov/pubmed/35251821
http://dx.doi.org/10.7759/cureus.21750
_version_ 1784661667770007552
author Kuwahara, Masaatsu
Noma, Mitsuki
Sunakawa, Takuya
Shirai, Kunihiro
Kohama, Keisuke
Miyawaki, Atsushi
Hirata, Jun-ichi
author_facet Kuwahara, Masaatsu
Noma, Mitsuki
Sunakawa, Takuya
Shirai, Kunihiro
Kohama, Keisuke
Miyawaki, Atsushi
Hirata, Jun-ichi
author_sort Kuwahara, Masaatsu
collection PubMed
description Stenotrophomonas maltophilia, an opportunistic pathogen, can cause bacteremia in immunocompromised and debilitated patients. A 50-year-old man with severe coronavirus disease 2019 (COVID-19) was admitted to our hospital’s intensive care unit where he underwent extracorporeal membrane oxygenation and ventilatory support. On day 25, he developed S. maltophilia bacteremia originating from an indwelling central venous catheter. After confirming susceptibility, trimethoprim-sulfamethoxazole (80 mg/400 mg) was administered thrice daily. Following improvement, he was weaned from ventilation, recovered sufficiently, and was discharged on day 53. To the best of our knowledge, this is the first report of a patient recovering after antimicrobial treatment for S. maltophilia bacteremia associated with severe COVID-19.
format Online
Article
Text
id pubmed-8890587
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-88905872022-03-04 Stenotrophomonas maltophilia Bacteremia Associated With Severe COVID-19: Successful Treatment With Appropriate Antimicrobial Therapy Kuwahara, Masaatsu Noma, Mitsuki Sunakawa, Takuya Shirai, Kunihiro Kohama, Keisuke Miyawaki, Atsushi Hirata, Jun-ichi Cureus Emergency Medicine Stenotrophomonas maltophilia, an opportunistic pathogen, can cause bacteremia in immunocompromised and debilitated patients. A 50-year-old man with severe coronavirus disease 2019 (COVID-19) was admitted to our hospital’s intensive care unit where he underwent extracorporeal membrane oxygenation and ventilatory support. On day 25, he developed S. maltophilia bacteremia originating from an indwelling central venous catheter. After confirming susceptibility, trimethoprim-sulfamethoxazole (80 mg/400 mg) was administered thrice daily. Following improvement, he was weaned from ventilation, recovered sufficiently, and was discharged on day 53. To the best of our knowledge, this is the first report of a patient recovering after antimicrobial treatment for S. maltophilia bacteremia associated with severe COVID-19. Cureus 2022-01-30 /pmc/articles/PMC8890587/ /pubmed/35251821 http://dx.doi.org/10.7759/cureus.21750 Text en Copyright © 2022, Kuwahara et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Kuwahara, Masaatsu
Noma, Mitsuki
Sunakawa, Takuya
Shirai, Kunihiro
Kohama, Keisuke
Miyawaki, Atsushi
Hirata, Jun-ichi
Stenotrophomonas maltophilia Bacteremia Associated With Severe COVID-19: Successful Treatment With Appropriate Antimicrobial Therapy
title Stenotrophomonas maltophilia Bacteremia Associated With Severe COVID-19: Successful Treatment With Appropriate Antimicrobial Therapy
title_full Stenotrophomonas maltophilia Bacteremia Associated With Severe COVID-19: Successful Treatment With Appropriate Antimicrobial Therapy
title_fullStr Stenotrophomonas maltophilia Bacteremia Associated With Severe COVID-19: Successful Treatment With Appropriate Antimicrobial Therapy
title_full_unstemmed Stenotrophomonas maltophilia Bacteremia Associated With Severe COVID-19: Successful Treatment With Appropriate Antimicrobial Therapy
title_short Stenotrophomonas maltophilia Bacteremia Associated With Severe COVID-19: Successful Treatment With Appropriate Antimicrobial Therapy
title_sort stenotrophomonas maltophilia bacteremia associated with severe covid-19: successful treatment with appropriate antimicrobial therapy
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890587/
https://www.ncbi.nlm.nih.gov/pubmed/35251821
http://dx.doi.org/10.7759/cureus.21750
work_keys_str_mv AT kuwaharamasaatsu stenotrophomonasmaltophiliabacteremiaassociatedwithseverecovid19successfultreatmentwithappropriateantimicrobialtherapy
AT nomamitsuki stenotrophomonasmaltophiliabacteremiaassociatedwithseverecovid19successfultreatmentwithappropriateantimicrobialtherapy
AT sunakawatakuya stenotrophomonasmaltophiliabacteremiaassociatedwithseverecovid19successfultreatmentwithappropriateantimicrobialtherapy
AT shiraikunihiro stenotrophomonasmaltophiliabacteremiaassociatedwithseverecovid19successfultreatmentwithappropriateantimicrobialtherapy
AT kohamakeisuke stenotrophomonasmaltophiliabacteremiaassociatedwithseverecovid19successfultreatmentwithappropriateantimicrobialtherapy
AT miyawakiatsushi stenotrophomonasmaltophiliabacteremiaassociatedwithseverecovid19successfultreatmentwithappropriateantimicrobialtherapy
AT hiratajunichi stenotrophomonasmaltophiliabacteremiaassociatedwithseverecovid19successfultreatmentwithappropriateantimicrobialtherapy